Nitric oxide (. NO) and its reactive derivative peroxynitrite (ONOO-)
have been implicated in the pathogenesis of multiple sclerosis (MS). T
hey ore cytotoxic to oligodendrocytes and neurones in culture by inhib
iting the mitochondrial respiratory chain (complexes II/III and IV) an
d inhibiting certain key intracellular enzymes. Recently NO has been i
mplicated as a Possible aetiological factor in reversible conduction b
lock in demyelinated axons. Inducible nitric oxide synthase (iNOS) is
upregulated in the central nervous system of animals with experimental
allergic encephalomyelitis (EAE) and in patients with MS. In some EAE
models inhibiting iNOS activity decreases disease severity whilst in
other models disease activity is exacerbated. Raised levels of nitrate
and nitrite, stable end-products of . NO/ONOO-, ore found in the cere
brospinal fluid serum and urine of patients with MS. CSF levels of nit
rate and nitrite correlate with blood-brain-barrier dysfunction, which
suggests that NO may ploy a role in inflammatory blood-brain-barrier
dysfunction. In a longitudinal study on 24 patients with relapsing rem
itting and secondary Progressive MS, raised serum nitrate and nitrite
levels correlated with a relapsing course and infrequent relapses. How
ever, no correlation was found between raised serum levels of nitrate
and nitrite and MRI activity, disease progression, or the development
of cerebral atrophy. In autoimmune mediated CNS demyelinating disease
NO may be a double-edged sword, mediating tissue damage on the one han
d and on the other hand modulating complex immunological functions whi
ch may be protective.